Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
50.71
-0.65 (-1.27%)
At close: Oct 14, 2026, 4:00 PM EDT
51.25
+0.54 (1.06%)
Pre-market: Oct 15, 2026, 5:32 AM EDT
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $490.53 million as of October 14, 2026. Its market cap has increased by 11.34% in one year.
Market Cap
490.53M
Enterprise Value
274.97M
1-Year Change
11.34%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $490.53M, an increase of 1,074.00%. That is a compound annual growth rate of 54.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 490.53M | -21.79% |
| Dec 31, 2025 | 627.18M | 150.23% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shattuck Labs | 534.94M |
| Valneva SE | 534.92M |
| Puma Biotechnology | 526.52M |
| DBV Technologies | 525.61M |
| Faeth Therapeutics | 516.81M |
| Aclaris Therapeutics | 497.53M |
| Monopar Therapeutics | 490.66M |
| CytomX Therapeutics | 485.92M |